{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:42:08Z","timestamp":1780778528044,"version":"3.54.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIAID, National Institutes of Health","award":["75N93019C00063"],"award-info":[{"award-number":["75N93019C00063"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The most commonly used animal models for evaluating the efficacy of HSV-2 candidate vaccines are mice and guinea pigs. While numerous HSV-2 vaccine candidates have been tested in these animals and were effective in reducing disease and mortality, these results did not predict the effectiveness of the vaccines in human trials. Infection of rhesus macaques rarely results in lesions or HSV-2 specific antibody responses. In seeking an animal model that better recapitulates human disease and that might be more predictive of the efficacy of prophylactic vaccines than mice and guinea pigs, we evaluated Cebus apella (C. apella), a New World primate, in an HSV-2 genital infection model. Infectious HSV-2 was cultured from vaginal swabs from all 4 animals for 9\u201314 days after intravaginal inoculation of HSV-2 seronegative monkeys. Two of 4 monkeys had vesicular lesions in the vagina or vulva. No neurological symptoms were noted. Recurrent lesions and HSV-2 DNA shedding after acute disease resolved was infrequent. UV irradiation of the genital area did not induce recurrent genital lesions or virus shedding. All 4 monkeys developed HSV-2 neutralizing antibodies as well as virus-specific CD4 and CD8 T cell responses. Reinfection of animals 15 to 19 months after primary infection did not result in lesions; animals had reduced virus shedding and a shorter duration of shedding compared with that during primary infection, suggesting that primary infection induced protective immunity. Primary fibroblasts from C. apella monkeys supported the growth of HSV-2 in vitro; in contrast, HSV-2 did not replicate above the titer of the input inoculum in fibroblasts from rhesus macaques. These observations suggest that the C. apella monkey has potential to serve as a model for evaluating the efficacy of prophylactic vaccines, antivirals, or monoclonal antibodies to HSV-2.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012477","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T17:40:54Z","timestamp":1725385254000},"page":"e1012477","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion"],"prefix":"10.1371","volume":"20","author":[{"given":"Kening","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennichi","family":"Dowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Koelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-7176","authenticated-orcid":true,"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"5","key":"ppat.1012477.ref001","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.","volume":"35","author":"L Corey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ppat.1012477.ref002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"EE Freeman","year":"2006","journal-title":"Aids"},{"issue":"12","key":"ppat.1012477.ref003","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erv.12.129","article-title":"The challenge of developing a herpes simplex virus 2 vaccine","volume":"11","author":"LK Dropulic","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"ppat.1012477.ref004","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/infdis\/155.5.914","article-title":"Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes","volume":"155","author":"LR Stanberry","year":"1987","journal-title":"J Infect Dis"},{"issue":"17","key":"ppat.1012477.ref005","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1128\/JVI.74.17.7963-7971.2000","article-title":"Construction, phenotypic analysis, and immunogenicity of a UL5\/UL29 double deletion mutant of herpes simplex virus 2","volume":"74","author":"X Da Costa","year":"2000","journal-title":"J Virol"},{"issue":"15\u201316","key":"ppat.1012477.ref006","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0264-410X(00)00446-1","article-title":"A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs.","volume":"19","author":"M Wachsman","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"ppat.1012477.ref007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/175.1.16","article-title":"A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.","volume":"175","author":"ME Boursnell","year":"1997","journal-title":"J Infect Dis"},{"key":"ppat.1012477.ref008","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06054","article-title":"Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.","volume":"4","author":"C Petro","year":"2015","journal-title":"Elife"},{"issue":"3","key":"ppat.1012477.ref009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/infdis\/158.3.602","article-title":"In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents","volume":"158","author":"B Meignier","year":"1988","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1012477.ref010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/JVI.01845-15","article-title":"A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.","volume":"90","author":"K Wang","year":"2016","journal-title":"J Virol"},{"issue":"39","key":"ppat.1012477.ref011","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes.","volume":"4","author":"S Awasthi","year":"2019","journal-title":"Sci Immunol."},{"issue":"1","key":"ppat.1012477.ref012","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"RB Belshe","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"ppat.1012477.ref013","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group","volume":"282","author":"L Corey","year":"1999","journal-title":"Jama"},{"issue":"21","key":"ppat.1012477.ref014","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"LR Stanberry","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"ppat.1012477.ref015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/146.3.397","article-title":"Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease","volume":"146","author":"LR Stanberry","year":"1982","journal-title":"J Infect Dis"},{"issue":"Suppl 11","key":"ppat.1012477.ref016","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1093\/clind\/13.Supplement_11.S935","article-title":"The mouse model and understanding immunity to herpes simplex virus","volume":"13","author":"JC Mester","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"9","key":"ppat.1012477.ref017","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1128\/JVI.73.9.7619-7626.1999","article-title":"The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL\/6 mice is almost entirely directed against a single immunodominant determinant","volume":"73","author":"ME Wallace","year":"1999","journal-title":"J Virol"},{"issue":"13","key":"ppat.1012477.ref018","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/j.1460-2075.1996.tb00690.x","article-title":"Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP","volume":"15","author":"R Tomazin","year":"1996","journal-title":"Embo j"},{"issue":"7","key":"ppat.1012477.ref019","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1128\/JVI.02509-10","article-title":"The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo","volume":"85","author":"JM Lubinski","year":"2011","journal-title":"J Virol"},{"issue":"9","key":"ppat.1012477.ref020","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/molbev\/msu185","article-title":"Evolutionary origins of human herpes simplex viruses 1 and 2","volume":"31","author":"JO Wertheim","year":"2014","journal-title":"Mol Biol Evol"},{"issue":"5","key":"ppat.1012477.ref021","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3322\/canjclin.24.5.258","article-title":"Herpes genitalis and its relationship to cervical cancer","volume":"24","author":"RH Kaufman","year":"1974","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"ppat.1012477.ref022","first-page":"501","article-title":"Genital herpesvirus hominis Type 2 infection of monkeys.","volume":"37","author":"WT London","year":"1971","journal-title":"Obstet Gynecol."},{"issue":"3968","key":"ppat.1012477.ref023","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.171.3968.297","article-title":"Genital herpesvirus hominis type 2 infection: an experimental model in cebus monkeys","volume":"171","author":"AJ Nahmias","year":"1971","journal-title":"Science"},{"issue":"3","key":"ppat.1012477.ref024","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3181\/00379727-139-36276","article-title":"Experimental Herpesvirus hominis type 2 infection in nonhuman primates","volume":"139","author":"SS Kalter","year":"1972","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"ppat.1012477.ref025","article-title":"Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus Macaques","volume":"93","author":"M Lo","year":"2019","journal-title":"J Virol"},{"issue":"2","key":"ppat.1012477.ref026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3181\/00379727-125-32100","article-title":"Experimental herpes simplex infection in the owl monkey","volume":"125","author":"DS Katzin","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"ppat.1012477.ref027","first-page":"1118","article-title":"A nonhuman primate model for the study of the cervical oncogenic potential of herpes simplex virus type 2","volume":"34","author":"WT London","year":"1974","journal-title":"Cancer Res"},{"issue":"2 pt 2","key":"ppat.1012477.ref028","first-page":"807","article-title":"A preliminary report on investigation of oncogenic potential of herpes simplex virus type 2","volume":"36","author":"AE Palmer","year":"1976","journal-title":"Cebus monkeys. Cancer Res"},{"issue":"1","key":"ppat.1012477.ref029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08830180305228","article-title":"Vaginal immunity in the HSV-2 mouse model.","volume":"22","author":"MB Parr","year":"2003","journal-title":"Int Rev Immunol."},{"issue":"3","key":"ppat.1012477.ref030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0190-9622(87)70232-1","article-title":"Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model","volume":"17","author":"JJ Perna","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ppat.1012477.ref031","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/166.3.500","article-title":"UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir","volume":"166","author":"JF Rooney","year":"1992","journal-title":"J Infect Dis"},{"key":"ppat.1012477.ref032","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2013.12.014","article-title":"Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain","volume":"450\u2013451","author":"R Colgrove","year":"2014","journal-title":"Virology"},{"issue":"1","key":"ppat.1012477.ref033","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/JVI.79.1.410-418.2005","article-title":"Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs","volume":"79","author":"Y Hoshino","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"ppat.1012477.ref034","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/JVI.72.4.2760-2764.1998","article-title":"The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks","volume":"72","author":"JA Lekstrom-Himes","year":"1998","journal-title":"J Virol"},{"issue":"10","key":"ppat.1012477.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102702","article-title":"Legend or Truth: Mature CD4(+)CD8(+) Double-Positive T Cells in the Periphery in Health and Disease.","volume":"11","author":"M Hagen","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"ppat.1012477.ref036","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/jama.1990.03440030105030","article-title":"Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes","volume":"263","author":"BV Brock","year":"1990","journal-title":"Jama"},{"issue":"9","key":"ppat.1012477.ref037","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/379043","article-title":"Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.","volume":"188","author":"A Wald","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1012477.ref038","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/588676","article-title":"Herpes simplex virus viremia during primary genital infection","volume":"198","author":"C Johnston","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1012477.ref039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-3148.2009.00951.x","article-title":"Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine?","volume":"20","author":"D Juhl","year":"2010","journal-title":"Transfus Med"},{"issue":"3","key":"ppat.1012477.ref040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01311111","article-title":"Association of herpes simplex virus with platelets of experimentally infected mice","volume":"76","author":"B Forghani","year":"1983","journal-title":"Arch Virol"},{"issue":"2","key":"ppat.1012477.ref041","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3181\/00379727-153-39523","article-title":"Latent Herpesvirus hominis from trigeminal and sacral dorsal root ganglia of Cebus monkeys","volume":"153","author":"WC Reeves","year":"1976","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"ppat.1012477.ref042","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1128\/jvi.71.10.7903-7910.1997","article-title":"Mutations in the 5\u2019 end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.","volume":"71","author":"K Wang","year":"1997","journal-title":"J Virol"},{"issue":"15","key":"ppat.1012477.ref043","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1128\/JVI.00474-07","article-title":"Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells","volume":"81","author":"Y Hoshino","year":"2007","journal-title":"J Virol"},{"issue":"7","key":"ppat.1012477.ref044","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/molbev\/msx113","article-title":"Ancient Recombination Events between Human Herpes Simplex Viruses","volume":"34","author":"S Burrel","year":"2017","journal-title":"Mol Biol Evol"},{"issue":"1","key":"ppat.1012477.ref045","doi-asserted-by":"crossref","first-page":"e114989","DOI":"10.1371\/journal.pone.0114989","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.","volume":"10","author":"KJ Looker","year":"2015","journal-title":"PLoS One."},{"issue":"3","key":"ppat.1012477.ref046","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000149320","article-title":"Kinetics of human antibody responses to primary genital herpes simplex virus infection","volume":"18","author":"S Kohl","year":"1982","journal-title":"Intervirology"},{"issue":"11","key":"ppat.1012477.ref047","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/JVI.02659-05","article-title":"Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes","volume":"80","author":"N Hosken","year":"2006","journal-title":"J Virol"},{"key":"ppat.1012477.ref048","doi-asserted-by":"crossref","first-page":"867962","DOI":"10.3389\/fimmu.2022.867962","article-title":"HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens.","volume":"13","author":"DM Koelle","year":"2022","journal-title":"Front Immunol."},{"issue":"22","key":"ppat.1012477.ref049","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1128\/JVI.75.22.11178-11184.2001","article-title":"Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons","volume":"75","author":"T Liu","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"ppat.1012477.ref050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/10799900260100150","article-title":"Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection","volume":"22","author":"M Minami","year":"2002","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"ppat.1012477.ref051","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaci.2016.02.025","article-title":"Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-\u03b3 therapy","volume":"138","author":"P Arts","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"ppat.1012477.ref052","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/520094","article-title":"Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis","volume":"196","author":"Y Sergerie","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"ppat.1012477.ref053","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1086\/605498","article-title":"Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors","volume":"49","author":"RD Bradford","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ppat.1012477.ref054","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1128\/jvi.63.3.1354-1359.1989","article-title":"Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus","volume":"63","author":"E Feduchi","year":"1989","journal-title":"J Virol"},{"issue":"13","key":"ppat.1012477.ref055","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/j.1460-2075.1996.tb00689.x","article-title":"Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47","volume":"15","author":"K Ahn","year":"1996","journal-title":"Embo j"},{"issue":"2","key":"ppat.1012477.ref056","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/jvi.56.2.489-494.1985","article-title":"Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species","volume":"56","author":"PJ Johansson","year":"1985","journal-title":"J Virol"},{"issue":"16","key":"ppat.1012477.ref057","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM197410172911606","article-title":"Recovery of herpes simplex virus from human sacral ganglions","volume":"291","author":"JR Baringer","year":"1974","journal-title":"N Engl J Med"},{"issue":"2","key":"ppat.1012477.ref058","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.virol.2009.11.041","article-title":"Simian TRIM5alpha proteins reduce replication of herpes simplex virus","volume":"398","author":"N Reszka","year":"2010","journal-title":"Virology"},{"issue":"Suppl 2","key":"ppat.1012477.ref059","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0684.2008.00328.x","article-title":"AIDS pathogenesis: a tale of two monkeys","volume":"37","author":"G. Silvestri","year":"2008","journal-title":"J Med Primatol"},{"issue":"11","key":"ppat.1012477.ref060","doi-asserted-by":"crossref","first-page":"e1000657","DOI":"10.1371\/journal.ppat.1000657","article-title":"Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.","volume":"5","author":"I Messaoudi","year":"2009","journal-title":"PLoS Pathog."},{"issue":"3","key":"ppat.1012477.ref061","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13550280290049705","article-title":"Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys","volume":"8","author":"TM White","year":"2002","journal-title":"J Neurovirol"},{"issue":"10","key":"ppat.1012477.ref062","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/344754","article-title":"Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1).","volume":"35","author":"JI Cohen","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"23","key":"ppat.1012477.ref063","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1128\/JVI.01055-12","article-title":"A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM","volume":"86","author":"K Wang","year":"2012","journal-title":"J Virol"},{"issue":"16","key":"ppat.1012477.ref064","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1128\/JVI.01303-15","article-title":"Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2","volume":"89","author":"RM Newman","year":"2015","journal-title":"J Virol"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T17:41:39Z","timestamp":1725385299000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012477"}},"subtitle":[],"editor":[{"given":"Donna M.","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012477","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}